Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3470165 | 0.82 | PARP1 (0.37) | PARP1SIGMAR1PLA2G10PLA2G5 | |
| SCHEMBL14536511 | 0.80 | SIGMAR1 (0.43) | SIGMAR1PLA2G10PLA2G5 | |
| SCHEMBL583320 | 0.78 | SIGMAR1 (0.49) | SIGMAR1PLA2G10PLA2G5 | |
| SCHEMBL1149470 | 0.78 | SIGMAR1 (0.49) | SIGMAR1PLA2G10PLA2G5 | |
| SCHEMBL8894875 | 0.77 | ZDHHC9 (0.40) | PARP1PLA2G10PLA2G5 | |
| SCHEMBL4771744 | 0.77 | SIGMAR1 (0.47) | SIGMAR1PLA2G10PLA2G5 | |
| Bromide SCHEMBL583318 | 0.77 | SIGMAR1 (0.47) | SIGMAR1PLA2G10PLA2G5 | |
| Hydrochloric Acid SCHEMBL8209880 | 0.77 | SIGMAR1 (0.47) | SIGMAR1PLA2G10PLA2G5 | |
| SCHEMBL4134315 | 0.76 | SIGMAR1 (0.50) | SIGMAR1PLA2G10PLA2G5 | |
| SCHEMBL649131 | 0.76 | SIGMAR1 (0.50) | SIGMAR1PLA2G10PLA2G5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240108607-A1 | METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF | FUJIFILM CORPORATION (JP) | 2024-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108607-A1 | METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF | C9, C5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | PARP1 2285/4885SIGMAR1 1106/4885PLA2G10 3178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.